reference/9953518

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9953518

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Comparative Study\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	1307
issn	1527-7755 0732-183X
issueIdentifier	8
pageRange	1301-1307
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	1301
bibliographicCitation	Burstein HJ, Sun Y, Dirix LY, Jiang Z, Paridaens R, Tan AR, Awada A, Ranade A, Jiao S, Schwartz G, Abbas R, Powell C, Turnbull K, Vermette J, Zacharchuk C, Badwe R. Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer. J Clin Oncol. 2010 Mar 10;28(8):1301–7. doi: 10.1200/jco.2009.25.8707. PMID: 20142587.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16e50495893cadf39e63939d803aeb4f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_109e1011fa49989b5cd0fb0a3d929339 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_926b8a5aa401ef939af3d49a95ac4020 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a66793368cde25e3f71af4d3890fcaf4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3edec6567d999cb34ee1bbd4fbfda143 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10a647b206a92461f52a8311454acccf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60d87e37f11315cccab7a96272ff330e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a6385cc60f6cb978d4d909a59a831c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89cd07d4e4e754e15c44f96f4ad0a158 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12121f0961d85d67cce6c3dc360f0fc4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a26c1b35bafff2c68e760bbaf821130 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c8f801211579616bde25476ed00b8a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_827643aa9e54b39df67afee0c480314b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa95dc87a9fc1b824427414d0d95b9a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8ee6e6132e44817bfbbb7509fee2032 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37ad1e669fd0d49514c2ef09eddc64be
date	2010-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1200/jco.2009.25.8707 https://pubmed.ncbi.nlm.nih.gov/20142587
isPartOf	https://portal.issn.org/resource/ISSN/0732-183X https://portal.issn.org/resource/ISSN/1527-7755 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer
discusses	http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0018350 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0543872 http://id.nlm.nih.gov/mesh/M0291428 http://id.nlm.nih.gov/mesh/M0028048
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011804Q000627 http://id.nlm.nih.gov/mesh/D018719Q000037 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D001943Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000068878 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000911Q000009 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D064420 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011804Q000008 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D011804Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9915743 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11499 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245740308 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459

Total number of triples: 78.